Subscribe free

Cytoreductive Surgery & Peritoneum ·

Surgical Limits in Cytoreduction for Pseudomyxoma Peritonei

Surgeons need to consider that extensive perigastric dissection during cytoreductive surgery can impair postoperative recovery without affecting oncologic outcomes.

  • Patients undergoing severe perigastric dissection (GCL4) had delayed oral intake, longer reliance on parenteral nutrition, and extended hospital stays.
  • Major morbidity, 30-day mortality, and long-term survival rates remained consistent across surgical levels.

Tailoring recovery strategies may be essential for patients with extensive dissection; an exploratory nomogram can help predict nutritional needs post-surgery.

  • Key predictors of delayed recovery included female sex, longer operative time, and the extent of perigastric dissection.

Journal Article by Aulicino M, Abatini C (…) Santullo F et 7 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Cytoreductive Surgery & Peritoneum.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Cytoreductive Surgery & Peritoneum

The latest stitches

Ann Surg Oncol28 Aug 2026

Prophylactic HIPEC Improves Survival in Advanced Colorectal Cancer

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.

All papers in Cytoreductive Surgery & Peritoneum →